Background: Gcn5-related N-acetyltransferases (GNATs) modify proteins in all domains of life. Results: The structure of a GNAT was determined in complex with a protein substrate. Conclusion: Specificity of the GNAT-protein interaction is dictated by an extensive interaction surface compared with GNATpeptide structures. Significance: This is the first structure of a GNAT-protein acetylation complex, and it may enable structure-based identification and engineering of GNAT substrates.
versatile. Although important members are histone acetyltransferases, the domain was first identified in aminoglycoside acetyltransferases and more recently in non-histone bacterial protein acetyltransferase (Pat) enzymes (7) . To date, only structures of GNAT complexes with short peptide substrates are available in databases. GNATs are now known to acetylate a diversity of protein substrates. Thus, a detailed characterization of the GNAT-substrate interface is critical for understanding GNAT specificity for protein targets, given the prevalence of lysine in biological proteomes.
In bacteria, many members of the multidomain AMP-forming acyl-CoA synthetase family are regulated by N ⑀ -lysine acetylation, as was first identified in Salmonella enterica for acetyl-CoA synthetase (SeAcs WT ) (8) . Acetylation of residue Lys 609 of SeAcs WT by the S. enterica protein acetyltransferase Pat (SePat WT ) leads to enzyme inactivation that can be reversed by the CobB sirtuin-type NAD ϩ -dependent deacetylase ( Fig.  1A ) (9) . SePat WT consists of a GNAT catalytic domain and a larger domain of unknown function (Fig. 1B) (10) . Studies of SePat WT homologues in other bacteria show that these acetyltransferases can regulate a wide range of acyl-CoA synthetases that all share a conserved PX 4 GK motif near the C-terminus of these proteins. The lysine in this motif is catalytic and is the target of acetylation. The roles of the proline and glycine residues are unknown and are not critical for acyl-CoA synthetase activity (11) . Interestingly, the presence of the PX 4 GK motif is necessary but not always sufficient for acetylation of these enzymes, suggesting that additional determinants lie outside of the signature sequence (12) .
To gain insight into how specificity governs recognition and modification in a reversible lysine acetyl-lysine signaling pathway, we characterized the interaction interface between a GNAT and a protein substrate. We determined the structure of the GNAT domain of the Streptomyces lividans PatA (SlPatA WT ) enzyme (Fig. 1 , C and D) and used the ClusPro version 2.0 server to identify potential interacting surfaces between the GNAT domain of SlPatA (hereafter referred to as SlPatA GNAT ) and the C-terminal domain of SeAcs (hereafter referred to as SeAcs CTD ), a substrate of SlPatA WT for which a three-dimensional crystal structure was available (PDB entries 1PG3 and 1PG4) (13) . We demonstrated that SlPatA
GNAT acetylated SeAcs
CTD in vivo and in vitro and that reversing charges near a predicted interface prevented interaction and SeAcs CTD acetylation. To test the biological relevance of the interaction model, we tethered the SlPatA GNAT domain to SeAcs CTD in multiple orientations with cross-linkers that resulted in spacing between the proteins ranging between 2 and 20 Å. We identified a single orientation that resulted in acetylation of SeAcs CTD when SlPatA GNAT was linked to SeAcs CTD by a direct disulfide bond, demonstrating catalysis in an enzymesubstrate complex with limited movement. We report the structure of the catalytic complex composed of the SlPatA GNAT domain and SeAcs CTD at 1.9 Å resolution. The structure revealed a constellation of determinants needed for recognition of a protein substrate by the SlPat GNAT domain.
EXPERIMENTAL PROCEDURES
Bacterial Strains and Growth Conditions-All strains, plasmids, and oligonucleotides used in this study are listed in Tables 1-3 . Escherichia coli and S. enterica strains were grown at 37°C in lysogeny broth (LB; Difco) (14) or no-carbon essential minimal medium (15) supplemented with sodium acetate (10 mM), MgSO 4 (1 mM), and ampicillin (100 g/ml). When necessary, antibiotics were used at the following concentrations: ampicillin, 100 g/ml; carbenicillin, 100 g/ml; tetracycline, 10 g/ml; kanamycin, 50 g/ml. L-(ϩ)-arabinose was added at varying concentrations (0 -25 M) to induce the expression of SlPatA GNAT cloned into the expression vector pBAD30 (16) . Growth experiments were performed at 37°C using a microtiter plate and a microtiter plate reader (Bio-Tek Instruments).
Molecular Techniques-DNA manipulations were performed using standard techniques (17) . Restriction endonucleases were purchased from Fermentas. DNA was amplified using Pfu Ultra II Fusion DNA polymerase (Agilent) or Herculase II Fusion DNA polymerase (Agilent). Site-directed mutagenesis was per- formed using the QuikChange TM site-directed mutagenesis kit (Agilent). Plasmids were isolated using the Wizard Plus SV Miniprep kit (Promega), and PCR products were purified using the Wizard SV Gel and PCR Clean-Up System (Promega). DNA sequencing was performed using BigDye (ABI PRISM) protocols, and dye-terminator sequencing reactions were resolved and analyzed by capillary electrophoresis at the University of Georgia Genomics Facility. Oligonucleotide primer sequences are listed in Table 3 .
Construction of Complementation Plasmids-The allele encoding the GNAT domain of wild-type SlPatA (residues Met 1 -Leu 194 ) was amplified from S. lividans TK24 genomic DNA using primers listed in Table 3 . Primers used in the amplification changed the first codon of SlPatA from TTG to the more common ATG start codon. The amplified fragment was cut with EcoRI and KpnI and ligated into pBAD30 cut with the same enzymes. The resulting plasmid, pSlPatA11, directed the synthesis of SlPat GNAT in response to L-(ϩ)-arabinose. The plasmid directing the synthesis of variant SlPatA GNAT E123Q was generated by site-directed mutagenesis using primers listed in Table 3 .
Plasmids for in Vivo Two-hybrid System Assays-Alleles encoding the wild-type SlPatA GNAT domain, variant SlPatA GNAT E121R, and variant SlPatA GNAT D185R were amplified from plasmids pSlPatA27, pSlPatA33, and pSlPatA35, respectively, using primers listed in Table 3 and SeAcs CTD R613D were amplified from plasmids pACS38, pACS42, and pACS44, respectively, using primers listed in Table 3 . DNA fragments were cut with NotI and BamHI and then ligated into plasmids pACTR-V-Zif-AP and pBRGP, which had been cut with NotI and BamHI. The resulting plasmids are listed in Table 2 .
SlPatA GNAT Overproduction Plasmids-The allele encoding the GNAT domain of SlPatA (residues Met 1 -Leu 194 ) was amplified from S. lividans TK24 genomic DNA with primers listed in Table 3 . The primers used were designed to change the first codon of SlPatA from TTG to the more common ATG start codon. The amplified fragment was cut with KpnI and SalI and ligated into pKLD66 (18) cut with the same enzymes. The resulting plasmid pSlPatA14 directed the synthesis of wild-type SlPatA GNAT fused at its N terminus to a His 6 -maltose-binding protein (MBP) tag cleavable by recombinant tobacco etch virus (rTEV) protease using protocols described previously (19) . Plasmids directing the synthesis of variants SlPatA GNAT S73C, SlPatA GNAT A110C, and SlPatA GNAT A164C were generated from plasmid pSlPatA14 using site-directed mutagenesis using primers listed in Table 3 . were generated from plasmid pACS38 by site-directed mutagenesis using primers listed in Table 3 .
Full-length SeAcs Overproduction Plasmids-Plasmids directing the synthesis of variants SeAcs CTD R606E and SeAcs CTD R613D were generated from plasmid pACS33 ( Table 2 ) using site-directed mutagenesis. The resulting plasmids pACS60 and pACS61 directed the synthesis of variants SeAcs CTD R606E and SeAcs CTD R613D, respectively, each fused to an N-terminal His 6 tag cleavable by rTEV protease.
SlPatA GNAT Overproduction and Purification-Plasmids pSlPatA14, pSlPatA53, pSlPatA54, and pSlPatA56 were transformed into the ⌬pka derivative of E. coli C41 (DE3) (strain JE9314). The resulting strains were grown overnight and subcultured 1:100 (v/v) into 2 liters of LB containing ampicillin (100 g/ml). The cultures were grown with shaking at 25°C to A 600 ϳ0.7, and His 6 -MBP-SlPatA GNAT synthesis was induced with isopropyl ␤-D-1-thiogalactopyranoside (IPTG) (0.5 mM). Upon induction, the cultures were grown overnight at 25°C. Cells were harvested at 6000 ϫ g for 10 min at 4°C in an Avanti J-2 XPI centrifuge fitted with rotor JLA-8.1000 (Beckman Coulter). Cell pellets were resuspended in 30 ml of cold HisBind buffer A (Tris-HCl buffer (50 mM, pH 8), NaCl (500 mM), and imidazole (5 mM)) containing phenylmethanesulfonyl fluoride (PMSF; 1 mM). Cells were placed on ice and lysed by sonication for 1 min (2-s pulse followed by 4 s of cooling) at level 7 in a model 550 sonic dismembrator (Fisher). The extract was cleared by centrifugation at 4°C for 30 min at 43,367 ϫ g. His 6 -tagged SlPatA GNAT was purified from the soluble fraction by nickel affinity purification using a 1-ml bed volume of His-Pur nickel-nitrilotriacetic acid resin (Thermo). Unbound proteins were eluted off of the column by extensive washing with buffer A. The column was then washed with buffer B1 (Tris-HCl buffer (50 mM, pH 8), NaCl (500 mM), and imidazole (15 mM)), and SlPatA GNAT was eluted from the column with buffer C (Tris-HCl buffer (50 mM, pH 8), NaCl (500 mM), and imidazole (250 mM)). All fractions containing His 6 -MBP-SlPatA GNAT were combined. rTEV protease was added to His 6 -MBPSlPatA GNAT , and the SlPatA GNAT /rTEV mixture was incubated at room temperature for 3 h. The SlPatA GNAT /rTEV mixture was dialyzed at 4°C against buffer C (Tris-HCl (50 mM, pH 8), NaCl (500 mM)) twice for 3 h and again against buffer C containing imidazole (5 mM) for 12 h. After cleavage and dialysis, 
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protein mixtures were passed over the 1-ml HisTrap column using the buffers described above, and the untagged proteins were eluted in the flow-through and buffer A wash. Purified SlPatA GNAT was analyzed by SDS-PAGE. Fractions containing SlPatA GNAT were pooled together. SlPatA GNAT was stored in Tris-HCl buffer (50 mM, pH 8.0) containing NaCl (100 mM) and glycerol (10%, v/v). Tris(2-carboxyethyl)phosphine (0.3 mM) and EDTA (0.5 mM) were included in the storage buffer for SlPatA GNAT cysteine variants. SlPatA GNAT concentration was determined by measuring absorbance at 280 nm. The molar extinction coefficient used to calculate SlPatA GNAT concentration was 17,420 M Ϫ1 cm Ϫ1 . The purification protocol for SlPatA GNAT for crystallography was similar to the one described above except that the purified, untagged protein was dialyzed into Tris-HCl buffer (10 mM, pH 8.0) and concentrated to 11 mg/ml before flash freezing into liquid nitrogen.
Selenomethionine-labeled SlPatA GNAT was overproduced as follows. Plasmid pSlPatA14 was transformed into strain JE9314, and a 1-liter culture of the resulting strain was grown overnight in M9 glucose medium. The culture was used to reinoculate 2 ϫ 2 liters of fresh M9 glucose medium at a 1:100 inoculum, and the culture was grown to an A 600 of ϳ1. The culture was cooled on ice to 16°C for 10 min, and a defined amino acid mixture containing lysine (100 mg/liter), threonine (100 mg/liter), phenylalanine (100 mg/liter), leucine (50 mg/liter), isoleucine (50 mg/liter), valine (50 mg/liter), and selenomethionine (50 mg/liter) was added to suppress methionine biosynthesis. The culture was grown at 37°C for 30 min before the addition of IPTG (1 mM) to induce SlPatA GNAT expression. The culture was grown overnight at 37°C, and the protein was purified and stored for crystallography as described above.
Purification of SeAcs WT and SeAcs CTD -Plasmids pACS38, pACS44, pACS56, pACS57, pACS58, pACS60, and pACS61 were transformed into a ⌬pka derivative of E. coli C41 (DE3) (JE9314) to prevent acetylation prior to overproduction. The resulting strains were grown overnight and subcultured 1:100 (v/v) into 2 liters of LB containing ampicillin (100 g/ml). The cultures were grown with shaking at 25°C to A 600 ϳ0.7, and protein synthesis was induced with IPTG (0.25 mM). Upon induction, the cultures were grown overnight at 25°C.
SeAcs
WT and SeAcs CTD proteins were purified and stored as described above for SlPatA GNAT with modifications. During the first purification step, the His 6 -SeAcs-bound resins were washed with buffer B (Tris-HCl buffer (50 mM, pH 8), NaCl (500 mM), and imidazole (20 mM)) before His 6 -SeAcs proteins were eluted with buffer C. His 6 -SeAcs CTD -bound resins were washed with buffer B3 (Tris-HCl buffer (50 mM, pH 8), NaCl (500 mM), and imidazole (40 mM)) before elution with buffer C. In the second purification step, SeAcs WT proteins and SeAcs CTD proteins did not adsorb to the column and were present in the flow-through fractions. Proteins were stored in Tris-HCl buffer (50 mM, pH 8.0) containing NaCl (100 mM) and glycerol (10%, v/v). Tris(2-carboxyethyl)phosphine (0.3 mM) and EDTA (0.5 mM) were included in the storage buffer for SlPatA GNAT Two-hybrid System Assay and ␤-Galactosidase Activity Measurement-E. coli strain KDZif1⌬Z harboring compatible plasmids were grown overnight in 1 ml of nutrient broth supplemented with kanamycin and carbenicillin. The following day, strains were subcultured 1:100 into 200 l of nutrient broth supplemented with kanamycin, carbenicillin, and IPTG (200 M) to induce expression from two-hybrid screen plasmids. Strains were grown for 3.5 h at 37°C with shaking at medium intensity in a BioTek plate reader (BioTek Instruments, Inc.). Absorbance values of the cultures were measured in the microtiter plate at a 650 nm wavelength using a Spectramax Plus 384 spectrophotometer (Molecular Devices).
The ␤-galactosidase activity of the cultures was measured as described (20, 21) , with modifications. Cultures were diluted 20 l into 80 l of permeabilization solution (Na 2 HPO 4 (100 mM), KCl (20 mM), MgCl 2 (2 mM), hexadecyltrimethylammonium bromide (0.06%), sodium deoxycholate (0.04%), 2-mercaptoethanol (38 mM)). Samples were shaken for 5 s in a Spectramax Plus 384 spectrophotometer (Molecular Devices) to mix. Permeabilized cells were then diluted 25 l into 150 l of substrate solution (Na 2 HPO 4 (60 mM), NaH 2 PO 4 (40 mM), O-nitrophenyl-␤-galactoside (1 mg/ml), 2-mercaptoethanol (38 mM)). The absorbance at 420 nm was monitored in a 96-well plate using the Spectramax Plus 384 spectrophotometer. A unit of activity was defined as the amount of enzyme required to catalyze the hydrolysis of 1 nmol of O-nitrophenyl-␤-galactoside per min.
AMP-forming CoA Ligase Assays-SeAcs WT activity was measured using an NADH-consuming assay (22, 23) . Reactions (100-l total volume) contained HEPES buffer (50 mM, pH 7.5), tris(2-chloroethyl) phosphate (tris(2-carboxyethyl)phosphine; 1 mM), ATP (2.5 mM), CoA (0.5 mM), MgCl 2 (5 mM), KCl (1 mM), phosphoenolpyruvate (3 mM), NADH (0.1 mM), pyruvate kinase (1 unit), myokinase (5 unit), lactate dehydrogenase (1.5 units), and acetate (0.2 mM). Reactions were started by the addition of SeAcs WT (15 nM) . The absorbance at 340 nm was monitored in a 96-well plate using the Spectramax Plus UV-visible spectrophotometer (Molecular Devices). Enzyme specific activities were determined to be in the linear range for the assay and were calculated as described (22) . Values are reported as the mean Ϯ S.D.
In Vitro Acetylation-Protein acetylation was monitored using radiolabeled [1- 14 C]Ac-CoA (50 M; 56.8 mCi mmol Ϫ1 ) as described (23) (24) (25) . Briefly, reactions contained SeAcs WT or SeAcs CTD (3 M) and either SePat WT or SlPatA WT (1 M). Samples (10 l) were removed and quenched with 2 l of loading buffer (glycerol (50%), EDTA (1 mM), bromphenol blue (0.25%), xylene cyanol (0.25%)) before being resolved and visualized with SDS-PAGE (26) and Coomassie Blue staining (27) , respectively. Labeled proteins were visualized using a Typhoon FLA 9000 variable mode imager (GE Healthcare) equipped with ImageQuant TL software (GE Healthcare). Acetylation was quantified as a measure of the radiolabel signal and reported as digital light units. Gels and phosphor images were cropped to the SeAcs WT CTD were exchanged into cross-linking buffer (20 mM HEPES, pH 7.5, 100 mM NaCl, sparged with N 2 ) using Zeba Spin desalting columns (Pierce). SeAcs CTD proteins were immediately diluted into a 10-fold molar excess of aldriothiol-2 (AT-2, 2.05-Å cross-linker; Sigma), bis(maleimido)ethane (8.0-Å cross-linker; Thermo), 1,4-bis(maleimido)butane (10.9 Å cross-linker; Thermo), bis(maleimido)hexane (16.0-Å cross-linker; Thermo), or 1,4-di-(3Ј-(2Ј-pyridyldithio)-propionamido)butane (19.9-Å crosslinker; bioWorld) and allowed to react for 1 h at room temperature. Activated SeAcs CTD variants and SlPatA GNAT cysteine variants were desalted into cross-linking buffer as described above. SlPatA GNAT variants were diluted into a 5-fold molar excess of SeAcs CTD and allowed to react for 2 h at 4°C. AT-2 and 1,4-di-(3Ј-[2Ј-pyridyldithio]-propionamido)butane crosslinking reactions were quenched with iodoacetamide (10 mM). Bis(maleimido)ethane, 1,4-bis(maleimido)butane, and bis(maleimido)hexane cross-linking reactions were quenched with DTT (10 mM). Cross-linking reactions were analyzed by nonreducing SDS-PAGE to verify cross-linking and to quantify cross-linked species.
Cross-linked species were incubated with BisTris (100 mM, pH 6.0) and [1- 14 C]Ac-CoA (20 M; 56.8 mCi mmol Ϫ1 ) at 30°C for 1 h. Reactions were resolved by non-reducing SDS-PAGE and analyzed as described above. Gels and phosphor images were cropped to the wild-type SeAcs CTD -SlPatA GNAT complex bands.
Crystallization of SlPatA GNAT and SlPatA-SeAcs CTD ComplexSlPatA GNAT crystals were grown by small scale batch crystallization, where 4 l of concentrated protein at 10.7 mg/ml in Tris-HCl buffer (10 mM, pH 8.0) containing ethyl-CoA (2 mM) was mixed with 5 l of PEG solution (22% (w/v) monomethyl polyethylene glycol 5000 in MOPS buffer (100 mM, pH 7.0) containing MgCl 2 (25 mM), 2,2,2-trifluoroethanol (2% v/v), and glycerol (6%, v/v) (28) . Drops were immediately streak-seeded and then allowed to grow at room temperature for 1 week. Crystals grew to maximal dimensions of 300 ϫ 100 ϫ 100 m. For freezing, crystals were transferred to PEG solution containing ethyl-CoA (1 mM) and then transferred stepwise to a solution of monomethyl polyethylene glycol 5000 (22%, w/v), glycerol (20%, v/v), MOPS buffer (100 mM, pH 7.0) containing MgCl 2 (25 mM), 2,2,2-trifluoroethanol (2%, v/v), and ethyl-CoA (2 mM). Crystals were flash-frozen in liquid nitrogen. Selenomethionine protein crystals were grown under identical conditions except that all solutions lacked ethyl-CoA. SlPatA GNAT -SeAcs CTD complex crystals were grown by hanging drop diffusion, where 1 l of concentrated protein at 10.0 mg/ml in Tris-HCl buffer (10 mM, pH 8.0) containing CoA (2 mM) was mixed with 1 l of 11.2% (w/v) polyethylene glycol 8000, 100 mM 1,4-piperazinediethanesulfonic acid, pH 6.5, and 120 mM Li 2 SO 4 . Crystals formed spontaneously after 2 months and grew to a maximum dimension of 400 ϫ 50 ϫ 50 m. For freezing, crystals were transferred to paratone-N and then flash-frozen in liquid nitrogen.
X-ray Data Collection and Structural Refinement-X-ray diffraction data for the SlPatA GNAT crystals and SlPatA GNATSeAcs CTD complex crystals were collected at the SBC 19-ID and SBC 19-BM beamlines, respectively (Advanced Photon Source, Argonne, IL). The data sets were integrated and scaled with the program HKL3000 (29) . X-ray data collection statistics are given in Table 4 . The structure of the SlPatA
GNAT -

SeAcs
CTD complex was solved by molecular replacement using SlPatA GNAT and SeAcs CTD (PDB code 1PG4) as search models where residues in loops were deleted. The structure of SlPatA GNAT was solved by single-wavelength anomalous diffraction using crystals containing selenomethionine protein. The HKL3000 suite was used to build an initial model of selenomethionine SlPatA GNAT utilizing the programs SHELX, mlphare, DM, and ARP/wARP (30 -32) . This initial structure was used without any further refinement as a molecular replacement model to determine the structure of the native protein using the program Phaser (32, 33 (Fig. 1B) . SlPatA GNAT was sufficient for functionality in vivo through its ability to substitute for SePat WT during growth on 10 mM acetate. As expected, expression of SlPatA GNAT inhibited growth of an S. enterica ⌬pat ⌬cobB strain but allowed growth of an S. enterica ⌬pat cobB ϩ strain, which retained the ability to deacetylate acetyllysine (Fig. 1, A and E) .
Interaction Model for SlPatA GNAT 
GNAT -SeAcs
CTD binary complex (described below). The location for the linkage was identified by first creating a computational model for the complex from the high resolution structures of the individual domains.
The three-dimensional structure of SlPatA GNAT was determined to 1.5 Å (Fig. 1, C and D, and ). The most similar structure to SlPatA GNAT was that of the GNAT domain from Sulfolobus solfataricus Pat (PDB code 3F8K), with a root mean square deviation of 1.32 Å over 131 residues. The major secondary structure differences between the SsPat GNAT and SlPatA GNAT exist along the protein substrate-binding surface. The structure of SlPatA GNAT determined here was combined with the previously reported structures of SeAcs WT (PDB codes 1PG3 and 1PG4) (13) to generate computer models of the interaction interface using the ClusPro 2.0 server (36 -39 Fig. 1F . Notably, SlPatA GNAT was predicted to interact predominantly with SeAcs CTD . Fig. 2A (Fig. 2, A and B) . Purified singleCys variants were cross-linked using sulfhydryl-specific crosslinkers with reported lengths of 2.05-19.9 Å (Fig. 2C) . Crosslinking in all nine configurations was successful with at least four different cross-linkers for each combination (Fig. 2E , Coomassie Blue-stained images).
The ability of the SlPatA GNAT to acetylate SeAcs CTD in each cross-linked complex was used as a measure of the biochemical relevance of the orientation allowed by the cross-linker length constraints. In the absence of a cross-link, SlPatA GNAT acetylation of SeAcs CTD was efficient only when SlPatA GNAT was in 10-fold molar excess of the SeAcs CTD (Fig. 2D ). As seen in Fig.  2E , SlPatA GNAT acetylated SeAcs CTD in nearly all orientations tested when the spacer length was Ն8 Å. The single exception was the complex between variants SlPatA GNAT A110C and SeAcs CTD A538C, in which we did not observe acetylation for any of the cross-linked complexes tested. Notably, only complex SlPatA GNAT S73C-SeAcs CTD H567C resulted in detectable acetylation when a direct disulfide bond between the cysteine residues of each protein held the complex together. This direct disulfide bond severely restricted the interactions between SlPatA GNAT and SeAcs CTD , yet the acetylation signal was strong (Fig. 2E) . Thus, we hypothesized that the protein orientations in the SlPatA S73C -SeAcs H567C complex reflected the interactions of these proteins in vivo. Significantly, residues Ser 73 of SlPatA GNAT and His 567 of SeAcs CTD were positioned near one another in the ClusPro interaction model (Fig. 2A) .
Crystal Structure of the SlPatA GNAT -SeAcs CTD Complex at 1.9 Å Resolution-To visualize how variants SlPatA GNAT S73C and SeAcs CTD H567C interacted, we crystallized the SlPatA GNAT S73C-SeAcs CTD H567C complex formed with an 8-Å linker, and the structure was determined to 1.9 Å (Fig. 3, A-D, and Table 4 ). In the of SlPatA GNAT S73C-SeAcs CTD H567C structure, the catalytic Glu 123 residue of SlPatA GNAT was 4.7 Å away from the target Lys 609 of SeAcs CTD (Fig. 3, D and E) , a distance within the range observed for Tetrahymena Gcn5 bound to a lysine-containing peptide substrate (40, 41) .
The interface between SlPatA GNAT and SeAcs CTD included more than just the interactions between the Lys 609 -containing SeAcs WT loop and the primary active site of SlPatA GNAT ; for example, it included interactions that are well separated in the primary sequence. The interface shows good shape complementarity with a shape correlation statistic (Sc) of 0.54, which is similar to the 0.60 observed in the Gcn5 H3 peptide complex (PDB code 1QSN) (42) . These values fall within the expected range for this type of complex, where an antibody-antigen complex results in an Sc value from 0.64 to 0.68, whereas an aberrant interface will result in an Sc of around 0.35. The SlPatA GNATSeAcs CTD interaction surface was distinct and larger than that of the Gcn5-H3 peptide complex (Fig. 3, B, C, and F) . The interface between SlPatA GNAT and SeAcs CTD buried a total surface area of 2150 Å 2 , where this was 48% polar and 52% non-polar, which is typical for recognition surfaces. The distribution of hydrophobicity in the interface is roughly the same as across the total surface area of either protein. This is consistent with a transient interface in which specificity is driven by chargecharge interactions with minimal hydrophobic contributions. The size and disposition of the residues in the binding interface was consistent with the hypothesis that Pat substrate specificity involves elements outside the simple PX 4 GK loop motif (12) . However, the PX 4 GK loop does play a structural role in positioning Lys 609 into the active site cleft of SlPatA GNAT . The carbonyl oxygen of the preceding glycine residue hydrogen bonded to residue Arg 64 of SlPatA GNAT and facilitated a bend in the backbone loop conformation (⌽ 97°, 9°). Also located within the PX 4 GK loop, the carbonyl oxygens of SeAcs CTD FIGURE 4. SlPatA GNAT and SeAcs CTD residues at the interaction interface are conserved. A, alignment of sequences in and around the Acs CTD PX 4 GK motif (black box) from S. enterica (SeAcs, accession number NP_463140), Saccharomyces cerevisiae (Acs2p, accession number NP_013254), Halobacterium salinarum (HsAcs, accession number WP_0109027), and S. lividans (SlAcs, accession number EFD68454). Blue shaded boxes indicate conserved positively charged residues. *, fully conserved residue; :, residues with high similarity; ., residues with low similarity. B, alignment of GNAT domain from homologues of SlPatA (accession number EFD66247) from S. enterica (SePat, accession number XNP_461586), R. palustris (RpPat, accession number NP_494576), and M. tuberculosis (MtPat, accession number WP_003906490). Notation is described as above. Red and green shaded boxes indicate negatively charged and hydrophobic residues, respectively, observed at the SlPatA GNAT -SeAcs CTD interaction interface. Sequence alignment generated in ClustalW2 (45) .
Arg 606 and Ser 607 hydrogen-bond with the positively charged side chains of SlPatA GNAT residues Arg 79 and Arg 64 , respectively (Fig. 3E) . Similar to the Tetrahymena Gcn5 H3 complex, hydrophobic interactions were also involved in positioning the target lysine (40) . SlPatA GNAT residue Phe 66 packed against the methylene groups of SeAcs CTD residue Lys 609 (Fig. 3E ). In addition to the interactions with the PX 4 GK motif, there were complementary ionic interactions between the protein domains, where a large negatively charged surface patch on SlPatA GNAT interacted with a complementary positive patch on SeAcs CTD (Fig. 3, B and C) . A prominent group of arginine residues in SeAcs CTD (Arg 612 , Arg 613 , and Arg 616 ) lay on the surface of a short ␣-helix that followed the PX 4 GK motif (Fig.  3B) , where these are conserved in Acs homologues from bacteria, archaea, and eukaryotes ( Fig. 4A) (43) . These arginines interacted with a negative patch on SlPatA GNAT that included residues Phe 66 , Glu 160 , and Glu 184 (Fig. 3C ). These interactions most likely contribute to the specificity of the SlPatA GNAT domain for its substrate. SlPatA GNAT homologues shown to acetylate the cognate Acs from the same organism exhibit amino acid sequence conservation at several of the residues noted above (Fig. 4B) . (Fig. 6) . Amino acid substitutions near the active site lysine of AMP-forming CoA ligases have been shown to affect activity (11) .
In Vitro and in Vivo Evidence
We also demonstrated that variant SlPat GNAT E121R interacted with SeAcs WT in vivo and inhibited growth of an S. enterica ⌬pat ⌬cobB strain but not the growth of an S. enterica ⌬pat cobB ϩ strain. In contrast, variant SlPat GNAT D185R only slightly inhibited growth of the S. enterica ⌬pat ⌬cobB strain (Fig. 7) . These data were consistent with the observation that the SlPat D185R variant exhibited significantly weaker interactions with SeAcs CTD in the bacterial two-hybrid assay (Fig. 5) . When higher levels of variant SlPat GNAT D185R were present, the growth of S. enterica on 10 mM acetate was inhibited (Fig. 7) . These results were consistent with the idea that variant SlPat GNAT D185R and SeAcs CTD interactions were weakened but not abolished.
DISCUSSION
Mapping the interaction surface between the SlPatA GNAT and the globular protein substrate SeAcs CTD is a significant advance in our understanding of how protein lysine acetyltransferases recognize, with specificity, large globular protein targets. To generate an interaction model of a GNAT with a protein substrate, the crystal structure of SlPatA GNAT was first solved. The structure of SlPatA GNAT and SsPat WT , the most closely related structure, differed significantly at the predicted substrate interface. SsPat WT was crystallized after limited proteolysis, and the absence of amino acids (specifically residues 42-52 that link helix ␣2 to strand ␤2) may distort the active site cleft. SsPat WT acetylates the DNA-binding protein Alba, but it is unknown whether it can acetylate AMP-forming CoA ligases. Thus, we cannot rule out the possibility that the structural differences surrounding the SsPat WT substrate-binding cleft may represent distinct substrate specificity. Interestingly, the factors that contribute to specificity observed for SlPatA are different from those reported for methylmalonyl-CoA synthetase of Rhodopseudomonas palustris. In that case, a loop spanning residues 447-450 in the R. palustris methylmalonyl-CoA synthetase was identified as containing elements critical for binding to and subsequent acetylation by the R. palustris protein acetyltransferase (RpPat) enzyme (12) . The equivalent loop in SeAcs CTD (residues 565-568) is not involved in the SlPatA GNAT -SeAcs CTD interface, which highlights the complexity and difficulty in predicting GNAT substrate specificity from first principles. The structure of the acetylation complex revealed complementary electrostatic interactions between SlPatA GNAT and SeAcs CTD . The charged residues involved in the SlPatA GNATSeAcs CTD interface are conserved in only some species (Fig. 4, A  and B ) . B, reaction controls lacking SePat were incubated for 90 min and imaged as described above. Gels and phosphor images were cropped to the SeAcs bands and labeled as described in A. C, phosphor signal associated with each band in A and B was quantified as described under "Experimental Procedures." D, SeAcs, SeAcs R606E , and SeAcs R613D were incubated with SlPatA (white bars) or SePat (gray bars) at the ratio described above in the presence or absence of Ac-CoA. After 90 min, SeAcs activity was measured in an NADH consumption assay. All data points are mean Ϯ S.D. (error bars) (n ϭ 6). DLU, digital light units. D185R , triangles) in the absence of inducer during growth on no-carbon essential minimal medium supplemented with acetate (10 mM). B, growth of S. enterica ⌬pat cobB ϩ (squares) and S. enterica ⌬pat ⌬cobB (circles) strains producing variant SlPatA GNAT D185R (pGNAT D185R ) in the presence of inducer (no inducer (white), 5 M inducer (light gray), 10 M inducer (dark gray), 25 M inducer (black)) during growth on no-carbon essential minimal medium supplemented with acetate (10 mM). Growth experiments were performed at 37°C using a microtiter plate and a microtiter plate reader (Bio-Tek Instruments). All data points represent the mean value. All S.D. values are Ͻ0.015 absorbance units (n ϭ 4).
PatA-Acs interactions among species. Likewise, few of the PatA residues involved in the PatA-Acs interaction are conserved. Considering that the GNAT family of acetyltransferases is noted for its lack of primary sequence conservation (7), predicting interacting residues of GNATs in the absence of structural data remains challenging. The extensive interaction surface observed at the SlPatA GNAT -SeAcs CTD may be a key feature of PatA-Acs interactions. A large interaction surface would facilitate the evolution of distinct constellations of interactions between each GNAT and its protein substrate(s). Continued structural analysis of GNAT-substrate complexes will reveal the range of interactions that occur between GNATs and their protein substrates.
The GNAT-substrate interface identified in the SlPatA
GNAT -
SeAcs
CTD crystal structure is remarkably distinct from the Gcn5-H3 peptide complexes reported to date (Fig. 3, C and E) and reveals structural roles of residues within and distant from the PX 4 GK motif found in substrates of Pat-type GNATs. The structure of the SlPatA GNAT -SeAcs CTD interaction will serve as a model to further identify, validate, and engineer (11) specific globular protein targets of GNAT protein acetyltransferases.
